David Baram: Founder and CEO of EmendoBio

Episode 66

0:00-36:03

David Barmam, founder and CEO of Emendio Biotherapeutics, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how Emendo is working to evolve traditional CRISPR tools and create new nucleases customized to any genetic disease.

Publisher

BioBoss

Link

www.wyantsimboli.com/bioboss/david-baram-founder-and-ceo-of-emendobio/

Published

December 16, 2023

Duration

36 min

Format

Podcast

Category

Issues · Science

Source

RSS feed

Host

John Simboli

B

BioBoss

@bioboss

#davidbaram #founder #emendobio #lifesciences #investing

The Nile